Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA PIRAMAL ENTERPRISES AUROBINDO PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 12.5 -27.9 - View Chart
P/BV x 1.1 0.6 190.2% View Chart
Dividend Yield % 2.0 3.9 50.8%  

Financials

 AUROBINDO PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
PIRAMAL ENTERPRISES
Mar-22
AUROBINDO PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,0643,013 35.3%   
Low Rs5841,612 36.2%   
Sales per share (Unadj.) Rs400.3586.3 68.3%  
Earnings per share (Unadj.) Rs45.756.4 81.1%  
Cash flow per share (Unadj.) Rs64.984.3 77.0%  
Dividends per share (Unadj.) Rs9.0033.00 27.3%  
Avg Dividend yield %1.11.4 76.5%  
Book value per share (Unadj.) Rs419.41,487.0 28.2%  
Shares outstanding (eoy) m585.94238.66 245.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.13.9 52.2%   
Avg P/E ratio x18.041.0 44.0%  
P/CF ratio (eoy) x12.727.4 46.3%  
Price / Book Value ratio x2.01.6 126.3%  
Dividend payout %19.758.5 33.6%   
Avg Mkt Cap Rs m482,799551,910 87.5%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50921,350 161.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555139,933 167.6%  
Other income Rs m3,2267,201 44.8%   
Total revenues Rs m237,781147,134 161.6%   
Gross profit Rs m42,56662,822 67.8%  
Depreciation Rs m11,2656,658 169.2%   
Interest Rs m48644,799 1.1%   
Profit before tax Rs m34,04018,567 183.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2565,108 142.1%   
Profit after tax Rs m26,78413,459 199.0%  
Gross profit margin %18.144.9 40.4%  
Effective tax rate %21.327.5 77.5%   
Net profit margin %11.49.6 118.7%  
BALANCE SHEET DATA
Current assets Rs m181,227251,882 71.9%   
Current liabilities Rs m81,560195,756 41.7%   
Net working cap to sales %42.540.1 105.9%  
Current ratio x2.21.3 172.7%  
Inventory Days Days251,969 1.3%  
Debtors Days Days624 1,476.5%  
Net fixed assets Rs m155,104816,105 19.0%   
Share capital Rs m586477 122.8%   
"Free" reserves Rs m245,174354,414 69.2%   
Net worth Rs m245,760354,891 69.2%   
Long term debt Rs m2,492437,784 0.6%   
Total assets Rs m336,3311,067,987 31.5%  
Interest coverage x71.01.4 5,018.4%   
Debt to equity ratio x01.2 0.8%  
Sales to assets ratio x0.70.1 532.3%   
Return on assets %8.15.5 148.6%  
Return on equity %10.93.8 287.4%  
Return on capital %13.98.0 174.0%  
Exports to sales %31.10-   
Imports to sales %11.90.2 5,533.5%   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,965302 9,275.2%   
Fx inflow Rs m77,2451,125 6,864.4%   
Fx outflow Rs m31,524302 10,455.6%   
Net fx Rs m45,721824 5,550.1%   
CASH FLOW
From Operations Rs m50,16587,496 57.3%  
From Investments Rs m-32,116-22,262 144.3%  
From Financial Activity Rs m-29,693-69,880 42.5%  
Net Cashflow Rs m-11,6747,000 -166.8%  

Share Holding

Indian Promoters % 48.8 43.5 112.1%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 39.9 95.1%  
FIIs % 21.4 32.1 66.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 56.5 85.3%  
Shareholders   358,459 259,635 138.1%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Piramal Enterprises

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Piramal Enterprises Share Price Performance

Period Aurobindo Pharma Piramal Enterprises S&P BSE HEALTHCARE
1-Day -1.08% -2.82% 0.15%
1-Month -16.15% -4.78% -1.70%
1-Year -35.59% -40.81% -6.84%
3-Year CAGR 0.44% -1.81% 20.62%
5-Year CAGR -8.06% -11.61% 10.61%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Piramal Enterprises share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Piramal Enterprises the stake stands at 43.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Piramal Enterprises.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Piramal Enterprises paid Rs 33.0, and its dividend payout ratio stood at 58.5%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Piramal Enterprises.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 389 Points | Nifty Today Ends Below 18,500 | IT Stocks Witness Selling Pressure(Closing)

After opening the day on a flat note, Indian shares reversed early gains to end the day 0.6% lower.